A top-10 pharma unified safety signal detection across three business units on Qinecsa Vigilance Workbench.
Vaccine and pharma signal teams worked separately on legacy applications and outdated in-house visualization tools. Qinecsa deployed QVW in two phases with FAERS and EVDAS integration and the Analytics module, set up to support a Consumer Health divestment. The page reports unified signal processes, better audit readiness and simpler IT, with no figures.
Qinecsa is a pharmacovigilance technology and services company, used by pharma to automate adverse event intake and run signal detection and safety operations
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Qinecsa on its own site — read the original case study on qinecsa.com ↗
Related use cases
- 01Aurinia replaced manual adverse event intake with Qinecsa's Reportum after launching LUPKYNIS.
- 02A top-5 pharma cut manual case processing by 60% with Reportum after a therapy launch.
- 03A Japanese healthcare group automated multilingual adverse event intake with Reportum.
- 04A top-10 pharma cut manual case handling by up to 80% with Reportum across 110 countries.
- 05A pharma fixed pharmacovigilance gaps after critical EMA findings by moving to a new validated safety database.
- 06Transforming Content Operations for 2x Faster Time to Market